Characterization of influenza A (H7N9) viruses isolated from human cases imported into Taiwan.
A novel avian influenza A (H7N9) virus causes severe human infections and was first identified in March 2013 in China. The H7N9 virus has exhibited two epidemiological peaks of infection, occurring in week 15 of 2013 and week 5 of 2014. Taiwan, which is geographically adjacent to China, faces a large risk of being affected by this virus. Through extensive surveillance, launched in April 2013, four laboratory-confirmed H7N9 cases imported from China have been identified in Taiwan. The H7N9 virus isolated from imported case 1 in May 2013 (during the first wave) was found to be closest genetically to a virus from wild birds and differed from the prototype virus, A/Anhui/1/2013, in the MP gene. The other three imported cases were detected in December 2013 and April 2014 (during the second wave). The viruses isolated from cases 2 and 4 were similar in the compositions of their 6 internal genes and distinct from A/Anhui/1/2013 in the PB2 and MP genes, whereas the virus isolated from case 3 exhibited a novel reassortment that has not been identified previously and was different from A/Anhui/1/2013 in the PB2, PA and MP genes. The four imported H7N9 viruses share similar antigenicity with A/Anhui/1/2013, and their HA and NA genes grouped together in their respective phylogenies. In contrast with the HA and NA genes, which exhibited a smaller degree of diversity, the internal genes were heterogeneous and provided potential distinctions between transmission sources in terms of both geography and hosts. It is important to strengthen surveillance of influenza and to share viral genetic data in real-time for reducing the threat of rapid and continuing evolution of H7N9 viruses.
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Ji-Rong
JR
Yang
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Chuan-Yi
CY
Kuo
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Hsiang-Yi
HY
Huang
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Fu-Ting
FT
Wu
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Yi-Lung
YL
Huang
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Chieh-Yu
CY
Cheng
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Yu-Ting
YT
Su
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC; School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan, ROC.
Ho-Sheng
HS
Wu
Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan, ROC.
Ming-Tsan
MT
Liu
D019143:Evolution, Molecular; D005260:Female; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype / Q000235:genetics* / Q000302:isolation & purification*; D007251:Influenza, Human / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D013624:Taiwan